Skip to content
Gleam logo

Gleam

Gleam is a YC Summer 2023 (S23) company. Based in San Francisco, CA, USA. Team of 4.

  • Artificial Intelligence
  • Biotech
  • Healthcare

About Gleam

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Gleam automates data entry for clinical research sites, pulling data from any source and pushing it into electronic data capture systems. The work it replaces is manual transcription by site staff who would otherwise spend hours on data entry instead of patient-facing tasks like screening, retention, and adverse event documentation.

Go-to-market

Clinical research sites adopt Gleam without complex installation or system integrations, pointing to a self-serve or lightweight onboarding motion targeting site coordinators and research teams directly.

From the Y Combinator listing

How Gleam describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Automating Data Entry for Clinical Trials

Gleam automates data entry for clinical research sites.

Facts

Industry
B2B / B2B
Location
San Francisco, CA, USA
Team size
4
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works